title: What's blasting off in CML?
authors.forename: Pam
authors.initials: P
authors.lastname: Oestreicher
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D000069439:Dasatinib; D018450:Disease Progression; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration*; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012307:Risk Factors; D013844:Thiazoles / Q000627:therapeutic use